Educational Webinar with Dr. Joseph Mikhael MD and Dr. Christopher Farnsworth, PhD
European Myeloma Network Meeting – EMN 2024
Sebia booth: #9
Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.
Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma
Educational Webinar with Dr. Jack Maggiore from Loyola University Medical Center in Chicago, IL